fialuridine has been researched along with EBV Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blasberg, RG; Doubrovin, M; Doubrovina, E; Finn, R; Gallardo, HF; Koehne, G; Larson, SM; O'Reilly, RJ; Riviere, I; Sadelain, M; Zanzonico, P | 1 |
1 other study(ies) available for fialuridine and EBV Infections
Article | Year |
---|---|
[131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity.
Topics: Animals; Arabinofuranosyluracil; Cytotoxicity, Immunologic; Dose-Response Relationship, Radiation; Epstein-Barr Virus Infections; Hematologic Neoplasms; Humans; Immunotherapy, Adoptive; In Vitro Techniques; Iodine Radioisotopes; Mice; Mice, SCID; Radionuclide Imaging; Radiopharmaceuticals; T-Lymphocytes; Transduction, Genetic | 2006 |